NCT04272216 2025-09-09
RAVI Registry
Terumo Medical Corporation
Completed
Clinical Trials
9 trialsNCT04020185 2024-12-11
Safety and Efficacy Study of IMSA101 in Refractory Malignancies
ImmuneSensor Therapeutics Inc.
Phase 1/2 Completed
NCT03250299 2024-06-24
Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Basilea Pharmaceutica
Phase 1 Terminated
NCT04046250 2023-08-25
TK112690
Tosk, Inc.
Phase 2 Completed
NCT01851772 2021-01-12
Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer
Xoft, Inc.
Phase NA Completed
NCT01892293 2019-01-10
CT Antigen TCR-Engineered T Cells for Myeloma
Adaptimmune
Phase 1/2 Terminated
NCT01154140 2017-11-06
PROFILE 1014
Pfizer
Phase 3 Completed
NCT02587819 2016-04-14
Investigation of the Safety and Tolerability of BSCT (Anti-nf-P2X7) 10% Ointment
Biosceptre
Phase 1 Completed
NCT01045187 2012-08-01
Feasibility Study Using the Xoft System for the Treatment of Endometrial Cancer
Xoft, Inc.
Phase NA Completed